| Segment Reporting [Table Text Block] |
| Compute Services and Treasury Management segment |
|
June 30,
2026
|
|
|
December 31,
2025
|
|
|
Assets
|
|
$ |
96,017,868 |
|
|
$ |
49,455,174 |
|
|
Depreciation and amortization
|
|
|
- |
|
|
|
- |
|
|
Expenditures for additions to long-lived assets
|
|
|
(17,100,106 |
) |
|
|
- |
|
| |
|
|
|
|
|
|
|
|
|
Drug Discovery Services segment
|
|
|
|
|
|
|
|
|
|
Assets
|
|
$ |
1,634,178 |
|
|
$ |
1,930,898 |
|
|
Depreciation and amortization
|
|
|
51,425 |
|
|
|
121,261 |
|
|
Expenditures for additions to long-lived assets
|
|
|
(21,000 |
) |
|
|
- |
|
| |
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
|
Assets
|
|
$ |
2,723,910 |
|
|
$ |
1,502,274 |
|
|
Depreciation and amortization
|
|
|
3,225 |
|
|
|
7,777 |
|
|
Expenditures for additions to long-lived assets
|
|
|
- |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
Assets
|
|
$ |
100,375,956 |
|
|
$ |
52,888,346 |
|
|
Depreciation and amortization
|
|
|
54,650 |
|
|
|
129,038 |
|
|
Expenditures for additions to long-lived assets
|
|
|
(17,121,106 |
) |
|
|
- |
|
| |
|
Three Months Ended
June 30,
|
|
|
Six Months Ended
June 30,
|
|
| |
|
2026
|
|
|
2025
|
|
|
2026
|
|
|
2025
|
|
|
Compute Services and Treasury Management segment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$ |
3,207,345 |
|
|
$ |
- |
|
|
$ |
3,214,280 |
|
|
$ |
- |
|
|
Gains and (losses) from operations
|
|
|
(13,125,352 |
) |
|
|
- |
|
|
|
(17,421,620 |
) |
|
|
- |
|
|
Cost of operations (a)
|
|
|
4,098,199 |
|
|
|
- |
|
|
|
4,289,848 |
|
|
|
- |
|
|
Total operating (loss)
|
|
|
(14,016,206 |
) |
|
|
- |
|
|
|
(18,497,187 |
) |
|
|
- |
|
|
Segment (loss)
|
|
|
(14,016,206 |
) |
|
|
- |
|
|
|
(18,497,187 |
) |
|
|
- |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Drug Discovery Services segment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
|
7,647 |
|
|
|
2,682 |
|
|
|
36,023 |
|
|
|
112,992 |
|
|
Gains and (losses) from operations
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
Cost of operations (a)
|
|
|
930,704 |
|
|
|
899,077 |
|
|
|
1,944,940 |
|
|
|
1,876,810 |
|
|
Total operating (loss)
|
|
|
(923,057 |
) |
|
|
(896,395 |
) |
|
|
(1,908,917 |
) |
|
|
(1,763,818 |
) |
|
Segment (loss)
|
|
|
(923,057 |
) |
|
|
(896,395 |
) |
|
|
(1,908,917 |
) |
|
|
(1,763,818 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
Gains and (losses) from operations
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
Cost of operations (a) (b)
|
|
|
2,388,747 |
|
|
|
1,763,473 |
|
|
|
4,650,586 |
|
|
|
3,183,097 |
|
|
Total operating (loss)
|
|
|
(2,388,747 |
) |
|
|
(1,763,473 |
) |
|
|
(4,650,586 |
) |
|
|
(3,183,097 |
) |
|
Segment (loss)
|
|
|
(2,388,747 |
) |
|
|
(1,763,473 |
) |
|
|
(4,650,586 |
) |
|
|
(3,183,097 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
|
3,214,992 |
|
|
|
2,682 |
|
|
|
3,250,303 |
|
|
|
112,992 |
|
|
Gains and (losses) from operations
|
|
|
(13,125,352 |
) |
|
|
- |
|
|
|
(17,421,620 |
) |
|
|
- |
|
|
Cost of operations (a)
|
|
|
7,417,650 |
|
|
|
2,662,550 |
|
|
|
10,885,374 |
|
|
|
5,059,907 |
|
|
Total operating (loss)
|
|
|
(17,328,010 |
) |
|
|
(2,659,868 |
) |
|
|
(25,056,691 |
) |
|
|
(4,946,915 |
) |
|
Other segment items
|
|
|
122,128 |
|
|
|
589,406 |
|
|
|
141,866 |
|
|
|
433,580 |
|
|
Net (loss)
|
|
|
(17,205,882 |
) |
|
|
(2,070,462 |
) |
|
|
(24,914,825 |
) |
|
|
(4,513,335 |
) |
|